Metric Snapshot
- Latest value
- $759,407,000
- Coverage range
- 31 Oct 2017 - 31 Jan 2026
- Fact rows
- 18
Shareable Research Card
SNPS - SYNOPSYS INC Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect
This metric view shows SNPS - SYNOPSYS INC cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect history from SEC company facts.
Use it to verify the latest reported value, compare nearby periods, and jump to a cross-company ranking when a curated insight exists.
- Context
- Latest reported period: Q4 2025
- Latest reported value
- $759,407,000
Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Values may differ by reporting period and company taxonomy.
Financial Metric Page
SYNOPSYS INC: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect
Latest period: Q4 2025. Period end: 31 Jan 2026. Units: USD. Frequency: quarterly and annual.
Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.
What This Metric Tells You
- Shows the reported level of cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect over 31 Oct 2017 - 31 Jan 2026.
- Includes year-over-year change points to highlight acceleration or slowdown.
- Built from 18 SEC fact rows for this metric and issuer.
How To Read This Chart
- Start with the latest point, then compare it with the prior periods to see direction.
- Use quarterly sequence to compare like-for-like periods.
- Use YoY change bars to separate growth from contraction across matching periods.
Official SEC Source
Source: SEC Company Facts
Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Reporting periods may differ by company.
Compare This Metric Across Companies
Compare latest available Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect levels across SEC-reporting companies, then open each company metric page for SEC-backed verification. Reporting periods may differ by company.
Metric Details
- Metric
- Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect (CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect)
- Taxonomy
- us-gaap
- Units tracked
- USD
- Frequency coverage
- quarterly and annual
- History range
- 31 Oct 2017 - 31 Jan 2026
- Facts on this page
- 18
- Description
- Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.
- Metric-level SEC endpoint
- Open SEC company concept
Chart Context
Compare periods with the same frequency first, then use YoY and TTM series to confirm whether changes are structural or one-off.
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect, Quarterly (USD)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect, YoY Quarterly Change (%)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect, Annual (USD)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect, YoY Annual Change (%)
SYNOPSYS INC Quarterly Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect (USD)
| Period | TTM Value | Value | YoY Chg | Change % | Start Date | End Date | Report | Filed | Fiscal Year | Fiscal Period |
|---|---|---|---|---|---|---|---|---|---|---|
| Q4 2025 | $759,407,000 | -$518,458,000 | -215% | 01 Nov 2025 | 31 Jan 2026 | 10-Q | 25 Feb 2026 | 2026 | Q1 | |
| Q4 2024 | $240,949,000 | +$79,068,000 | +25% | 01 Nov 2024 | 31 Jan 2025 | 10-Q | 25 Feb 2026 | 2026 | Q1 | |
| Q4 2023 | $320,017,000 | -$57,421,000 | -22% | 01 Nov 2023 | 31 Jan 2024 | 10-Q | 26 Feb 2025 | 2025 | Q1 | |
| Q4 2022 | $262,596,000 | +$46,002,000 | +15% | 01 Nov 2022 | 31 Jan 2023 | 10-Q | 23 Feb 2024 | 2024 | Q1 | |
| Q4 2021 | $308,598,000 | -$96,033,000 | -45% | 01 Nov 2021 | 31 Jan 2022 | 10-Q | 17 Feb 2023 | 2023 | Q1 | |
| Q4 2020 | $212,565,000 | -$184,320,000 | -653% | 01 Nov 2020 | 31 Jan 2021 | 10-Q | 18 Feb 2022 | 2022 | Q1 | |
| Q4 2019 | $28,245,000 | +$102,550,000 | +78% | 01 Nov 2019 | 31 Jan 2020 | 10-Q | 19 Feb 2021 | 2021 | Q1 | |
| Q4 2018 | $130,795,000 | +$311,358,000 | +70% | 01 Nov 2018 | 31 Jan 2019 | 10-Q | 21 Feb 2020 | 2020 | Q1 | |
| Q4 2017 | $442,153,000 | 01 Nov 2017 | 31 Jan 2018 | 10-Q | 25 Feb 2019 | 2019 | Q1 |
SYNOPSYS INC Annual Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect (USD)
| Period | Value | YoY Chg | Change % | Start Date | End Date | Report | Filed | Fiscal Year | Fiscal Period |
|---|---|---|---|---|---|---|---|---|---|
| 2025 | $1,005,008,000 | -$3,462,550,000 | -141% | 01 Nov 2024 | 31 Oct 2025 | 10-K | 22 Dec 2025 | 2025 | FY |
| 2024 | $2,457,542,000 | +$2,436,219,000 | +11425% | 01 Nov 2023 | 31 Oct 2024 | 10-K | 22 Dec 2025 | 2025 | FY |
| 2023 | $21,323,000 | +$36,642,000 | 01 Nov 2022 | 31 Oct 2023 | 10-K | 22 Dec 2025 | 2025 | FY | |
| 2022 | $15,319,000 | -$212,532,000 | -108% | 01 Nov 2021 | 31 Oct 2022 | 10-K | 19 Dec 2024 | 2024 | FY |
| 2021 | $197,213,000 | -$310,230,000 | -61% | 01 Nov 2020 | 31 Oct 2021 | 10-K | 12 Dec 2023 | 2023 | FY |
| 2020 | $507,443,000 | +$501,917,000 | +9083% | 01 Nov 2019 | 31 Oct 2020 | 10-K | 12 Dec 2022 | 2022 | FY |
| 2019 | $5,526,000 | +$330,600,000 | 01 Nov 2018 | 31 Oct 2019 | 10-K | 13 Dec 2021 | 2021 | FY | |
| 2018 | $325,074,000 | -$394,727,000 | -567% | 01 Nov 2017 | 31 Oct 2018 | 10-K | 15 Dec 2020 | 2020 | FY |
| 2017 | $69,653,000 | 01 Nov 2016 | 31 Oct 2017 | 10-K | 20 Dec 2019 | 2019 | FY |
* An asterisk sign (*) next to the value indicates that the value is likely invalid.